Lessee, Operating Lease, Liability, Undiscounted Excess Amount in USD of Immix Biopharma, Inc. from Q1 2024 to Q3 2025
-
Taxonomy & unit
-
us-gaap: USD
-
Description
-
Amount of lessee's undiscounted obligation for lease payments in excess of discounted obligation for lease payments for operating lease.
-
Summary
-
Immix Biopharma, Inc. quarterly Lessee, Operating Lease, Liability, Undiscounted Excess Amount history and growth rate from Q1 2024 to Q3 2025.
- Immix Biopharma, Inc. Lessee, Operating Lease, Liability, Undiscounted Excess Amount for the quarter ending September 30, 2025 was $399K, a 16.7% decline year-over-year.
Lessee, Operating Lease, Liability, Undiscounted Excess Amount, Quarterly (USD)
Lessee, Operating Lease, Liability, Undiscounted Excess Amount, YoY Quarterly Growth (%)